# Master Validation Pipeline (v9.0)

This is the comprehensive, chronological checklist of all validations performed for the v9.0 construct. 

## 🛠️ Phase 1: Sequence & Structure
- [x] **1.1 Sequence Assembly:** Python script assembled GLP-1(A2G) + EAAAK + MANF + EAAANSTAAKIETDAAAK + IgG1 Fc(LALA).
- [x] **1.2 BLAST Identity:** 100% human identity for MANF, Pro-glucagon, and IgG1. No off-target hits.
- [x] **1.3 Structure Prediction:** ESMFold API and Phyre2.
- [x] **1.4 Physics Relaxation:** OpenMM (Amber14) energy minimization to fix AI clashes.
- [x] **1.5 MolProbity:** Clashscore 0.30 (100th percentile), 0 bad bonds, 0% rotamer outliers.

## 🧬 Phase 2: Protease Cleavage & Spatial Activation
- [x] **2.1 ProP Furin Check:** 0 Furin cleavage sites in the entire sequence.
- [x] **2.2 Granzyme B Motif:** Local scan confirms IETD motif at pos 207.
- [x] **2.3 Linker Accessibility (SASA):** Granzyme B motif is highly exposed (463.17 Å²).

## 🎯 Phase 3: Receptor Docking & Interfaces (HDOCK)
- [x] **3.1 Target Docking (GLP-1R):** Score -298.87 (Confidence 0.95). Interface analysis proved canonical activation site binding (residues 1-9 and 25-30).
- [x] **3.2 Off-Target Docking (GCGR):** Score -306.13 (Artifact). Interface analysis proved a "blanket" interaction; the GLP-1 N-terminus is 16.54 Å away from the GCGR active site.
- [x] **3.3 Half-Life Docking (FcRn):** Score -258.14. Core FcRn binding residues (34, 35, 66, 91) are engaged.

## 🛡️ Phase 4: Immunogenicity & Developability
- [x] **4.1 B-Cell Epitopes (ElliPro):** Zero linear epitopes in the linker. 
- [x] **4.2 T-Cell Immunogenicity (IEDB):** NST glycan site successfully shields the IETD core from MHC-II.
- [x] **4.3 Glycosylation (NetNGlyc):** Confirms the NST site is actively recognized.
- [x] **4.4 Disulfide Bonds (DisLocate):** No rogue cysteines in the linker.
- [x] **4.5 Aggregation (AggreProt):** No aggregation hotspots in the linker.
- [x] **4.6 Solubility (SoluProt & ProtParam):** SoluProt score 0.880, GRAVY -0.503 (Highly soluble).
- [x] **4.7 Structural Homology (FoldSeek):** Isolated MANF matches native human MANF (TM-score 1.0).

## 🌪️ Phase 5: Molecular Dynamics (Stability)
- [ ] **5.1 All-Atom MD Simulation (BioBB):** 10ns GROMACS run (Currently Running).
- [ ] **5.2 MD Analysis:** RMSD, SASA, and inter-domain distance stability.
